Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta
- PMID: 3875658
Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta
Abstract
The lymphokine osteoclast-activating factor (OAF) was purified to homogeneity. OAF was produced by human peripheral blood mononuclear cells stimulated with concanavalin A and phorbol myristate acetate under serum-free culture conditions. OAF was purified by sequential gel filtration, ion-exchange, and reverse-phase HPLC by following bone resorptive activity. Homogeneity was indicated by the criteria of a single 17,800-dalton band on silver-stained polyacrylamide gels, a single pI 6.8 band on isoelectric focusing, and a single aminoterminal sequence. Purified OAF stimulated half-maximal release of calcium from fetal rat long bones at a concentration of approximately 0.66 ng/ml. The amino-terminal sequence of OAF was determined and found to be identical to that of interleukin 1 beta. Homogeneous OAF possessed an activity of 8.2 X 10(6) U/mg in the thymocyte proliferation assay. Because the m.w., isoelectric point, amino-terminal sequence, and specific activity in the thymocyte proliferation assay are the same for homogeneous OAF and interleukin 1 beta, we conclude that they are the same molecule, and that interleukin 1 beta is the major protein with OAF activity produced by lectin-stimulated peripheral blood mononuclear cells.
Similar articles
-
Purification and partial sequence of rabbit polymorphonuclear leukocyte-derived lymphocyte proliferation potentiating factor resembling IL-1 beta.J Immunol. 1988 Feb 15;140(4):1153-8. J Immunol. 1988. PMID: 3257771
-
Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.J Immunol. 1980 Apr;124(4):1954-62. J Immunol. 1980. PMID: 6444967
-
Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.J Clin Invest. 1974 May;53(5):1473-80. doi: 10.1172/JCI107696. J Clin Invest. 1974. PMID: 4825237 Free PMC article.
-
Osteoclast activating factor is now interleukin-1 beta: historical perspective and biological implications.J Oral Pathol. 1988 Apr;17(4):145-52. doi: 10.1111/j.1600-0714.1988.tb01515.x. J Oral Pathol. 1988. PMID: 3139850 Review.
-
P-cell stimulating factor: biochemistry, biology, and role in oncogenesis.Contemp Top Mol Immunol. 1985;10:121-46. doi: 10.1007/978-1-4684-4838-2_5. Contemp Top Mol Immunol. 1985. PMID: 2858358 Review. No abstract available.
Cited by
-
Growth factors and the regulation of bone remodeling.J Clin Invest. 1988 Feb;81(2):277-81. doi: 10.1172/JCI113318. J Clin Invest. 1988. PMID: 3276726 Free PMC article. Review. No abstract available.
-
Hypercalcemia in malignancy.West J Med. 1990 Dec;153(6):635-40. West J Med. 1990. PMID: 2293469 Free PMC article. Review.
-
Cloning and expression of the gene encoding the fructose-1,6-diphosphate-dependent L-(+)-lactate dehydrogenase of Streptococcus mutans.Infect Immun. 1990 May;58(5):1290-5. doi: 10.1128/iai.58.5.1290-1295.1990. Infect Immun. 1990. PMID: 2323817 Free PMC article.
-
Identification of a high-affinity receptor for native human interleukin 1 beta and interleukin 1 alpha on normal human lung fibroblasts.J Exp Med. 1987 Jan 1;165(1):70-86. doi: 10.1084/jem.165.1.70. J Exp Med. 1987. PMID: 2947968 Free PMC article.
-
Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta.Proc Natl Acad Sci U S A. 1987 Jul;84(13):4572-6. doi: 10.1073/pnas.84.13.4572. Proc Natl Acad Sci U S A. 1987. PMID: 2955410 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous